Efficacy and safety of reduced-dose non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: a meta-analysis of randomized controlled trials
10.1093/eurheartj/ehy802
Saved in:
Main Authors: | Wang KL, Lopes RD, Patel MR, Büller HR, Tan DS, Chiang CE, Giugliano RP |
---|---|
Other Authors: | PHARMACY |
Published: |
Oxford Academic
2020
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/176981 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Once- or twice-daily non-vitamin K antagonist oral anticoagulants in Asian patients with atrial fibrillation: A meta-analysis of randomized controlled trials
by: Wang KL, et al.
Published: (2020) -
Direct Oral Anticoagulant Dosing in Patients With Atrial Fibrillation: An Asian Perspective
by: Chao T.F.
Published: (2023) -
Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation
by: Piyameth Dilokthornsakul, et al.
Published: (2019) -
Cost-Effectiveness Analysis of Non-Vitamin K Antagonist Oral Anticoagulants Versus Warfarin in Thai Patients With Non-Valvular Atrial Fibrillation
by: Piyameth Dilokthornsakul, et al.
Published: (2020) -
Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis
by: Pongprueth Rujirachun, et al.
Published: (2020)